Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii

Bioorganic and Medicinal Chemistry Letters

Volumn 24, Issue 1, 2014, Pages 275-279

  Vullo, Daniela ^a   Del Prete, Sonia ^b   Osman, Sameh M ^c   De Luca, Viviana ^b   Scozzafava, Andrea ^a   Alothman, Zeid ^c   Supuran, Claudiu T ^a,c   Capasso, Clemente ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Class enzyme; Carbonic anhydrase; Enzyme inhibitor; Sulfonamide; Thalassiosira weissflogii

Indexed keywords

ACETAZOLAMIDE; BENZOLAMIDE; BRINZOLAMIDE; CARBONATE DEHYDRATASE; DELTA CARBONATE DEHYDRATASE; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; HYDROCHLOROTHIAZIDE; INDISULAM; SACCHARIN; SULFANILAMIDE; SULFONAMIDE; TOPIRAMATE; UNCLASSIFIED DRUG; VALDECOXIB; ZONISAMIDE; 3 BROMOSULFANILAMIDE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; LEISHMANIA DONOVANI; NONHUMAN; PORPHYROMONAS GINGIVALIS; STRUCTURE ACTIVITY RELATION; THALASSIOSIRA WEISSFLOGII; X RAY CRYSTALLOGRAPHY; ENZYME INHIBITION;

BACILLARIOPHYTA; NITZSCHIA ALBA; THALASSIOSIRA WEISSFLOGII;

CARBONIC ANHYDRASE; ENZYME INHIBITOR; SULFONAMIDE; THALASSIOSIRA WEISSFLOGII; Δ-CLASS ENZYME;

CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; DIATOMS; DOSE-RESPONSE RELATIONSHIP, DRUG; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 84891483722     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2013.11.021     Document Type: Article

References (46)

1. B.E. Alber, and J.G. Ferry Proc. Natl. Acad. Sci. U.S.A. 91 1994 6909
2. C. Kisker, H. Schindelin, B.E. Alber, J.G. Ferry, and D.C. Rees EMBO J. 15 1996 2323
3. B.E. Alber, C.M. Colangelo, J. Dong, C.M. Stålhandske, T.T. Baird, C. Tu, C.A. Fierke, D.N. Silverman, R.A. Scott, and J.G. Ferry Biochemistry 38 1999 13119
4. Y. Xu, L. Feng, P.D. Jeffrey, Y. Shi, and F.M. Morel Nature 452 2008 56
5. E.H. Cox, G.L. McLendon, F.M. Morel, T.W. Lane, R.C. Prince, I.J. Pickering, and G.N. George Biochemistry 39 2000 12128
6. C.T. Supuran Nat. Rev. Drug Disc. 7 2008 168
7. C.T. Supuran Front. Pharmacol. 2 2011 34
8. C.T. Supuran Bioorg. Med. Chem. Lett. 20 2010 3467
9. C.T. Supuran J. Enzyme Inhib. Med. Chem. 27 2012 759
10. C.T. Supuran J. Enzyme Inhib. Med. Chem. 26 2011 301
11. C.T. Supuran, A. Casini, and A. Scozzafava Med. Res. Rev. 23 2003 535
12. C.T. Supuran Expert Opin. Ther. Pat. 23 2013 677
13. S.B. Roberts, T.W. Lane, and F.M.M. Morel J. Phycol. 33 1997 845
14. T.W. Lane, and F.M. Morel Proc. Natl. Acad. Sci. U.S.A. 97 2000 4627
15. R.B.Y. Lee, J.A.C. Smith, and R.E.M. Rickaby J. Phycol. 49 2013 170
16. S. Del Prete, D. Vullo, A. Scozzafava, C. Capasso, and C.T. Supuran Bioorg. Med. Chem. 21 2013 10.1016/j.bmc.2013.10.045 in press
17. C.T. Supuran Expert Opin. Invest. Drugs 12 2003 283
18. A. Maresca, D. Vullo, A. Scozzafava, G. Manole, and C.T. Supuran J. Enzyme Inhib. Med. Chem. 28 2013 392
19. A. Maresca, A. Scozzafava, D. Vullo, and C.T. Supuran J. Enzyme Inhib. Med. Chem. 28 2013 384
20. D. Vullo, S. Isik, S. Del Prete, V. De Luca, V. Carginale, A. Scozzafava, C.T. Supuran, and C. Capasso Bioorg. Med. Chem. Lett. 23 2013 163
21. P. Joseph, S. Ouahrani-Bettache, J.L. Montero, I. Nishimori, T. Minakuchi, D. Vullo, A. Scozzafava, J.Y. Winum, S. Kohler, and C.T. Supuran Bioorg. Med. Chem. 19 2011 1172
22. S. Del Prete, D. Vullo, V. De Luca, V. Carginale, A. Scozzafava, C.T. Supuran, and C. Capasso Bioorg. Med. Chem. Lett. 23 2013 4067
23. S.A. Zimmerman, J.F. Tomb, and J.G. Ferry J. Bacteriol. 192 2010 135
24. J.G. Ferry Bioorg. Med. Chem. 21 2013 1392
25. A. Innocenti, S. Zimmerman, J.G. Ferry, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 3327
26. S. Zimmerman, A. Innocenti, A. Casini, J.G. Ferry, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 14 2004 6001
27. S.A. Zimmerman, J.G. Ferry, and C.T. Supuran Curr. Top. Med. Chem. 7 2007 901
28. J.G. Ferry, and C.T. Supuran Inhibition of the Archaeal and Bacterial β-Class and γ-Class Carbonic Anhydrases C.T. Supuran, J.Y. Winum, Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications 2009 Wiley Hoboken 285
29. D. Vullo, W. Leewattanapasuk, F.A. Mühlschlegel, A. Mastrolorenzo, C. Capasso, and C.T. Supuran Bioorg. Med. Chem. Lett. 23 2013 2647
30. A.M. Alafeefy, S. Isik, N.A. Al-Jaber, D. Vullo, H.A. Abdel-Aziz, A.E. Ashour, A.S. Awaad, C. Capasso, and C.T. Supuran Bioorg. Med. Chem. Lett. 23 2013 3570
31. C. Capasso, and C.T. Supuran Expert Opin. Ther. Pat. 23 2013 693
32. J. Krungkrai, and C.T. Supuran Curr. Pharm. Des. 14 2008 631
33. L. Syrjänen, A.B. Vermelho, I. de Almeida Rodrigues, S. Corte-Real, T. Salonen, P. Pan, D. Vullo, S. Parkkila, C. Capasso, and C.T. Supuran J. Med. Chem. 56 2013 7372
34. P. Pan, A.B. Vermelho, A. Scozzafava, S. Parkkila, C. Capasso, and C.T. Supuran Bioorg. Med. Chem. 21 2013 4472
35. C.T. Supuran Bioorg. Med. Chem. 21 2013 1377
36. D. Vullo, V. De Luca, A. Scozzafava, V. Carginale, M. Rossi, C.T. Supuran, and C. Capasso Bioorg. Med. Chem. 21 2013 4521
37. G. De Simone, V. Alterio, and C.T. Supuran Expert Opin. Drug Disc. 8 2013 793
38. S. Del Prete, S. Isik, D. Vullo, V. De Luca, V. Carginale, A. Scozzafava, C.T. Supuran, and C. Capasso J. Med. Chem. 55 2012 10742
39. A. Scozzafava, F. Carta, and C.T. Supuran Expert Opin. Ther. Pat. 23 2013 203
40. P. Pan, A.B. Vermelho, G. Capaci Rodrigues, A. Scozzafava, M.E. Tolvanen, S. Parkkila, C. Capasso, and C.T. Supuran J. Med. Chem. 56 2013 1761
41. E. Masini, F. Carta, A. Scozzafava, and C.T. Supuran Expert Opin. Ther. Pat. 23 2013 705
42. 11-13
43. Vullo, D.; Del Prete, S.; Osman, S.M.; De Luca, V.; Scozzafava, A.; AlOthman, Z.; Supuran, C.T.; Capasso, C. Bioorg. Med. Chem. Lett. 2013, 24, 240.
44. M.A. Pinard, C.D. Boone, B.D. Rife, C.T. Supuran, and R. McKenna Bioorg. Med. Chem. 21 2013 7210
45. L. Dubois, N.G. Lieuwes, A. Maresca, A. Thiry, C.T. Supuran, A. Scozzafava, B.G. Wouters, and P. Lambin Radiother. Oncol. 92 2009 423
46. C.T. Supuran, A. Di Fiore, and G. De Simone Expert Opin. Emerg. Drugs 13 2008 383